All Programs

Use the tool below to view all available Prova Series

Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
CME/CE
Chairperson Perspective: Acromegaly Care: Individualized Diagnosis and Management Strategies
0.25 credits
- Maria Fleseriu, MD, FACE
0.25 credits
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
MinuteCE®
Data Driving Recent Guideline Updates in Neoadjuvant Therapy for Resectable Melanoma
1.00 program credit
- John M. Kirkwood, MD
- Sapna Patel, MD
1.00 program credit
MinuteCE®
Innovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
1.00 credit 10 episodes
- John M. Kirkwood, MD
- Paolo A. Ascierto, MD
- Hussein Tawbi, MD, PhD
- Sapna Patel, MD
1.00 credit 10 episodes
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
MinuteCE®
Efficacy and Safety Outcomes for Adjuvant Immunotherapy Driving Guideline Recommendations for Stage IIB/IIC Melanoma
1.00 program credit
- Paolo A. Ascierto, MD
1.00 program credit
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
MinuteCE®
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed Stage III Melanoma
1.00 program credit
- Paolo A. Ascierto, MD
- Hussein Tawbi, MD, PhD
1.00 program credit
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
MinuteCE®
Insights From Global Key Opinion Leaders on Regional Regulatory and Guideline Nuances to Optimize Melanoma Management
1.00 program credit
- Hussein Tawbi, MD, PhD
- Paolo A. Ascierto, MD
1.00 program credit
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
MinuteCE®
Implementing Guideline-Concordant Care for a Patient With Newly Diagnosed BRAF-Mutant Stage IV Melanoma
1.00 program credit
- Hussein Tawbi, MD, PhD
- Sapna Patel, MD
1.00 program credit
Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
MinuteCE®
Data Driving Preferred Guideline Recommendations in First-Line Therapy for Metastatic Melanoma
1.00 program credit
- Paolo A. Ascierto, MD
- Hussein Tawbi, MD, PhD
1.00 program credit
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
CME/CE
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy
0.50 credits
- Kevin Kalinsky MD, MS
- Komal Jhaveri, MD, FACP
0.50 credits
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
CME/CE
Chairperson's Perspective: Innovative Approaches to IBS-C: Personalized Treatment for Better Outcomes
0.25 credits
- Darren Brenner, MD
0.25 credits
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
CME/CE
Non-CF Bronchiectasis: How Radiologists Can Drive Better Outcomes
1.00 credit
- Robert D. Suh, MD
- Lea Azour, MD
- Ashwin Basavaraj, MD
1.00 credit
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
CME/CE
Expert Perspectives From AUA 2025: Contextualizing the Evolving Landscape of Bladder Cancer
0.25 credits
- Neal Shore, MD, FACS
- Sarah Psutka, MD, MS
0.25 credits
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results 
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results 
Oncology and Hematology
SunRISe-1: 1-Year Durability and Patient-Reported Outcomes Results 
Managing Side Effects in FcRn Therapy: Best Practices for gMG
Managing Side Effects in FcRn Therapy: Best Practices for gMG
MinuteCE®
Managing Side Effects in FcRn Therapy: Best Practices for gMG
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
MinuteCE®
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
Diagnostic Advances in gMG: Effective Tools and Techniques
Diagnostic Advances in gMG: Effective Tools and Techniques
MinuteCE®
Diagnostic Advances in gMG: Effective Tools and Techniques
1.00 program credit
- Vera Bril, MD
- Hans Katzberg, MD
1.00 program credit

All Programs

Popular

Title

Share on ReachMD